Stent maker Peytant Solutions hired Dr. Craig Walker as chief medical officer and JD Simpson as chief commercial officer.

Levocloperastine with its dual mechanism of action acts on both the central bulbar cough centre and on peripheral receptors in the tracheobronchial tree. In preclinical studies, levocloperastine ...

Possible drug targets include receptors of the parasympathetic and sympathetic nervous systems that terminate in the tracheobronchial tree; hypertrophied bronchial smooth muscles; the complex ...

After hours: January 31 at 4:20:00 PM EST Loading Chart for MMSI ...